Long-term safety and effectiveness of eptinezumab in patients with prior preventive migraine treatment failures

被引：0
|
作者：
Ashina, Messoud [1 ,2 ]
Tepper, Stewart J. [3 ]
Gendolla, Astrid [4 ]
Sperling, Bjorn [5 ]
Ettrup, Anders [5 ]
Josiassen, Mette Krog [5 ]
Starling, Amaal J. [6 ]
机构：
[1] Copenhagen Univ Hosp, Rigshosp, Danish Headache Ctr, Dept Neurol, Copenhagen, Denmark
[2] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[3] New England Inst Neurol & Headache, Stamford, CT USA
[4] Praxis Gendolla, Essen, Germany
[5] H Lundbeck & Co AS, Copenhagen, Denmark
[6] Mayo Clin Arizona, Scottsdale, AZ USA
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-DP-0
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study
    Ashina, Messoud
    Lanteri-Minet, Michel
    Ettrup, Anders
    Christoffersen, Cecilie Laurberg
    Josiassen, Mette Krog
    Phul, Ravinder
    Sperling, Bjorn
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2023, 43 (05)
  • [22] Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden
    Ronan Mahon
    Andrea Lang
    Pamela Vo
    Jasper Huels
    Philip Cooney
    Andriy Danyliv
    Umakanth Vudumula
    Sreelatha Vadapalle
    Farooq Maniyar
    Peter J. Goadsby
    PharmacoEconomics, 2021, 39 : 357 - 372
  • [23] Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden
    Mahon, Ronan
    Lang, Andrea
    Vo, Pamela
    Huels, Jasper
    Cooney, Philip
    Danyliv, Andriy
    Vudumula, Umakanth
    Vadapalle, Sreelatha
    Maniyar, Farooq
    Goadsby, Peter J.
    PHARMACOECONOMICS, 2021, 39 (03) : 357 - 372
  • [24] Eptinezumab for the preventive treatment of migraine
    Villar-Martinez, Maria Dolores
    Moreno-Ajona, David
    Goadsby, Peter J.
    PAIN MANAGEMENT, 2021, 11 (02) : 113 - 122
  • [25] Impact of Eptinezumab on Patient-Reported Outcomes in Patients With Prior Preventive Treatment Failures
    Goadsby, Peter J.
    Barbanti, Piero
    Ettrup, Anders
    Christoffersen, Cecilie Laurberg
    Josiassen, Mette Krog
    Phul, Ravinder
    Sperling, Bjorn
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 60 - 60
  • [26] Impact of Eptinezumab on Patient-Reported Outcomes in Patients With Prior Preventive Treatment Failures
    Goadsby, P.
    Barbanti, P.
    Lambru, G.
    Ettrup, A.
    Christoffersen, C. L.
    Josiassen, M. K.
    Phul, R.
    Sperling, B.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [27] Impact of Eptinezumab on Patient-Reported Outcomes in Patients With Prior Preventive Treatment Failures
    Goadsby, P.
    Barbanti, P.
    Ettrup, A.
    Christoffersen, C.
    Josiassen, M.
    Phul, R.
    Sperling, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 408 - 408
  • [28] Preventive pharmacotherapy of migraine long-term treatment
    Manzoni, GC
    CONFINIA CEPHALALGICA, 1995, 4 (04): : 113 - 114
  • [29] Long-Term Use and Safety of Migraine Preventive Medications
    VanderPluym, Juliana
    Evans, Randolph W.
    Starling, Amaal J.
    HEADACHE, 2016, 56 (08): : 1335 - 1343
  • [30] Eptinezumab for Migraine Prevention in Patients with 2-4 Prior Treatment Failures: DELIVER Subpopulation Analysis
    Ashina, M.
    Lanteri-Minet, M.
    Pozo-Rosich, P.
    Ettrup, A.
    Christoffersen, C.
    Josiassen, M.
    Phul, R.
    Sperling, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 192 - 192
12345